(19)

(11)

EP 4 770 629 A1

(12)

(43) Date of publication: 08.07.2026 Bulletin 2026/28 (21) Application number: 24860910.9 (22) Date of filing: 28.08.2024

(51) International Patent Classification (IPC):  A61K 31/395(2006.01) A61K 31/02(2006.01) A61K 31/397(2006.01) (52) Cooperative Patent Classification (CPC): A61K 31/397; A61K 9/0019; A61K 9/1075; A61K 9/127; A61K 9/10; A61K 47/44; A61K 47/10; A61K 47/32; A61K 47/24; A61K 47/06 (86) International application number: PCT/US2024/044144 (87) International publication number: WO 2025/049544 (06.03.2025 Gazette 2025/10)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: GE KH MA MD TN (30) Priority: 29.08.2023 US 202363579413 P (71) Applicant: Anebulo Pharmaceuticals, Inc. Lakeway, Texas 78734 (US)	(72) Inventors: CUNDY, Kenneth C. Lakeway, Texas 78734 (US) COURTNEY, Margaret London W1W 7LT (GB) VAN HOOGEVEST, Peter Lakeway, Texas 78734 (US) (74) Representative: Brand Murray Fuller LLP  50 Eastcastle Street London W1W 8EA London W1W 8EA (GB)